Clinical Trials for Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency

Find clinical trials for artemis (dclre1c ) deficient severe combined immunodeficiency. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)

NCT ID: NCT05071222

The ARTEGENE trial is studying a new gene therapy for children and young adults with a specific kind of severe combined immunodeficiency (SCID) caused by a mutation in the DCLRE1C gene, also known ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Paris, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions